UC College of Pharmacy Wins Crystal APPLE Award
The
The Crystal APPLE (Academic-Practice Partnerships for Learning Excellence) award recognizes the contributions of faculty and administrators in colleges and schools of pharmacy and their collaborating practice partners pharmacies where staff conduct and support experiential education and provide students with clinical experience.
UCs College of Pharmacy collaborates with CPC, a three-store, neighborhood pharmacy chain in Covington, Ky., owned an operated by five members of the Ruwe family, all of whom graduated from UCs College of Pharmacy.
Education works both ways; we provide the experience for the students and they bring us fresh energy and talent, which keeps us up to date, says Don Ruwe (class of 1958). Dons brother, Paul (class of 1960), purchased CPC in 1983, and Don came on board shortly after; and so did their three, UC trained, pharmacist daughters: Paula, Elizabeth and Jeannie.
The award also recognizes Hegener, the on-site program coordinator and preceptor (educational instructor) at CPC. Hegener is an adjunct assistant professor of clinical pharmacy at UC and completed a pharmacy practice residency with an emphasis in community care at UC in 2006.
"Having the opportunity to precept student pharmacists and provide direct patient care is personally rewarding, and being nationally recognized for my time and effort makes it all the more fulfilling, comments Hegener, who in 2007 received the College of Pharmacys Preceptor of the Year award.
The Crystal APPLE awards program seeks to identify the most exemplary clinical education sites, says Lucinda Maine, PhD, AACP executive vice president and CEO.
Only eight colleges and schools of pharmacyout of approximately 100 nationwidereceive the APPLE award annually.
Michael Doherty is the director of experiential training at UCs
UC administrators and their practice partners will be honored with a Tiffany & Co. crystal apple and plaque at the 2009 AACP awards meeting in
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.